LysoPC(14:0/0:0)-d7

• UNSPSC Description:

  LysoPC(14:0/0:0)-d7 (14:0 Lyso PC-d7) is deuterium labeled LysoPC(14:0/0:0). LysoPC(14:0/0:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. LysoPC(14:0/0:0) has potent antispasmodic effect[1][2].

• Target Antigen:

  Endogenous Metabolite; Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Metabolic Enzyme/Protease;Others

• Field of Research:

  Metabolic Disease;Neurological Disease

• Smiles:

  O[C@H](COC(CCCCCCCCCCC([2H])(C([2H])(C([2H])([2H])[2H])[2H])[2H])=O)COP(OCC[N+](C)(C)C)([O-])=O

• Molecular Weight:

  474.62

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Tsukatani H, et al.Comparison of antispasmodic effect of synthetic lysolecithins with various fatty acid moieties on guinea pig ileum.J Pharmacobiodyn. 1984 Jun;7(6):400-6.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported